Neuraxis Inc — Cash Flow (NYSE:NRXS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -6.69 M-6.1 M-6.43 M -6.43 M Cash from investing activities -71.78 K-27.78 K-131.15 K -131.15 K Cash from financing activities 6.59 M9.74 M7.83 M 7.83 M Free cash flow -6.77 M-6.13 M-6.56 M -6.46 M

News

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis

Top Stock Reports for Meta, Bank of America & Procter & Gamble

NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth

Neuraxis stock rises after FDA clearance for abdominal pain treatment

Neuraxis reports preliminary Q3 2025 financial results with $2.1 million operating loss

The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis

Top Research Reports for Alphabet, IBM & Merck

Neuraxis enters $3.3 million at-the-market equity offering agreement

NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth

Itaúsa 1H25 presentation: Record results and 10% net income growth amid portfolio strength

Craig-Hallum initiates NeurAxis stock with buy rating on pediatric device